Biotron.com.au

While waiting for biotech stocks to correct, investors should be focused on performing due diligence, says Hartaj Singh of investment firm BTIG LLC. Growth in company valuations has outpaced sales for several years, but the coming weeks will see rapid...

In recent days, I have been in communication with several journalists who have been writing about issues that pertain to an issue in which I have some expertise: the alleged safety and efficacy of the huge number of neurotoxin-containing vaccines that...

FLEMINGTON, N.J., Sept. 19, 2015 /satPRnews.com/ — Arno Therapeutics, Inc. (OTCQB:ARNI), a clinical stage biopharmaceutical company primarily focused on the development of therapeutics for cancer and other life threatening diseases, today announced promising...

full-text: Emergence of Avian Influenza A(H7N9) Virus Causing Severe Human Illness — China, February–April 2013 Early Release Volume 62, Early Release May 1, 2013 For Questions About [insert type/label] Contact Us --> Emergence of Avian Influenza...

More options are always better, right? Obviously, that’s a “yes” when it comes to building our dream Tesla Model S. But big biopharma is getting nowhere fast with deals that build in options to license drug candidates. The number of...